TriangleHEALTH PROFESSIONAL · SOURCE READING
Dysgerminomas
Source: Ovarian Germ Cell Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 18, 2024 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of Recurrent Ovarian Germ Cell Tumors
Treatment options for patients with recurrent dysgerminomas include:
Cisplatin-based chemotherapy has been used effectively for patients with recurrent dysgerminoma with and without adjuvant radiation therapy.[1]
Source links and citations
Patients with recurrent pure dysgerminoma of the ovary are candidates for clinical trials. Some consideration should be given to the use of high-dose regimens with rescue.
Publication references
Read the original reference and check its publication notices.
Preserved source evidence · Not medical advice